No more crickets: The biopharma industry must speak out against the Trump administration’s fetal tissue ban

When President Donald Trump considered a range of options about regulating the use of fetal tissue in medical research, he made a simple political calculation. A ban would solidify support from religious anti-abortion advocates, while there would be no political cost to cutting off research that contributes to biomedical progress.

Trump bet correctly on the indifference and timidity of the biopharma industry. ...